← FDA DRUG APPROVALS

FDA NDA · NDA050762

TROVAN/ZITHROMAX COMPLIANCE PAK

Sponsor: PFIZER

APPLICATION
NDA050762
TYPE
NDA
ORIGINAL APPROVAL
1998-12-18
LATEST ACTION
1998-12-18
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION, TABLET
MARKETING STATUS
Discontinued

Products

TROVAN/ZITHROMAX COMPLIANCE PAKDiscontinued
AZITHROMYCIN DIHYDRATE EQ 1GM BASE,N/A, TROVAFLOXACIN MESYLATE N/A,EQ 100MG BASE · FOR SUSPENSION, TABLET · ORAL

Approval history

1998-12-18Type 4 - New Combination · Original · standard — Review ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →